- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.3 Amendment to Employment Agreement with Doug Baker, Dated March 10, 2020
- 10.4 Amendment to Employment Agreement with William Febbo, Dated March, 10, 2020
- 10.5 Amendment to Employment Agreement with Stephen Silvestro, Dated March, 10, 2020
- 10.6 Amendment to Employment Agreement with Miriam Paramore, Dated March, 10, 2020
- 21.1 List of Subsidiaries
- 23.1 Consent of Marcum LLP
- 31.1 Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13A-14(A)/15D-14(A), As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13A-14(A)/15D-14(A), As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.1 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Exhibit 10.5
Employment Agreement Addendum I
Addendum to agreement dated March 18, 2019
This first addendum to the employment agreement (the “Addendum”) is made this 10th day of March 2020, by and between OptimizeRx, Corporation (the “Company”), a Nevada Company, and Stephen Silvestro (the “Executive”).
Base Salary: The Executive will receive a base salary at the annualized rate of $300,000.00 (“Base Salary”), which will be paid in accordance with normal Company payroll practices and subject to the usual and applicable required withholding(s).
Bonus: The Executive will be eligible to participate in the Company’s Executive Bonus Plan, subject to terms and conditions, with an annual target bonus of 50% of base salary.
Effective Date: January 1, 2020
Acknowledgment:
Except as expressly set forth herein, all other terms of the Agreement remain in full force and effect.
OptimizeRx, Corporation | Stephen Silvestro | |||
By: | William Febbo | By: | Stephen Silvestro | |
Its: | Chief Executive Officer | Date: | March 10, 2020 | |
Date: | March 10, 2020 |